期刊文献+

Randall斑块在草酸钙肾结石形成中的作用 被引量:7

下载PDF
导出
摘要 尿路结石是泌尿外科最常见的疾病,由于其病因的复杂性及其高复发率,现在已成为泌尿外科所面临的挑战性难题。在泌尿系结石发病机制的认识过程中,产生了一系列学说,包括成核作用学说、结石基质学说、晶体抑制物质学说和Randall斑块学说等。Randall斑块在尿路结石的发病中占有重要地位。本文将从Randall斑块的发现及其位置、与活性氧和氧化应激、钙化纳米微粒之间的关系及其在草酸钙结石中的作用和肾小管内结晶被上皮细胞内吞、迁移与兰德尔斑块的关系做一综述。
作者 李扬 张士青
出处 《现代泌尿外科杂志》 CAS 2015年第9期679-682,共4页 Journal of Modern Urology
  • 相关文献

参考文献29

  • 1陈志强,姚林方,叶章群.特发性草酸钙结石研究现状[J].临床泌尿外科杂志,2005,20(5):257-260. 被引量:38
  • 2邓耀良.Randall斑的历史、现状和未来[J].广西医学,2005,27(1):10-12. 被引量:6
  • 3DAUDON M, BAZIN D, LETAVERNIER E. Randall's plaque as the origin of calcium oxalate kidney stones[J]. Urolithiasis. 2015,43 (Suppl 1:) 5-11. doi: 10. 1007/s00240-014-0703-y. PMID, 25098906.
  • 4陈书尚,高小峰,丁德英,周铁,王林辉,许传亮,孙颖浩.草酸钙肾结石患者肾乳头钙盐沉积特点及其形成机制[J].第二军医大学学报,2009,30(1):19-23. 被引量:7
  • 5EVAN AP, COE FL, LINGEMAN JE. Mechanism of formation of human calcium oxalate renal Anat Rec (Hoboken), 2007 17724713. stones on Randall's plaque[J] 290 (10): 1315-1323.
  • 6PMID KHAN SR. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? [J]. Urol Res,2012,40(2) 195-112. PMID: 22213019.
  • 7KHAN SR. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations [J]. J Urol, 2013,189 ( 3 ) : 803- 811.PMID:23022011.
  • 8CIFTCIOGLU N, MCKAY DS, MATHEW G, et al. Nanobac- teria: fact or fiction? Characteristics, detection, and medical im- portance of novel self-replicating, calcifying nanopartieles/JJ. J Investig Med, 2006,54(7) : 385-394. PMID: 17169260.
  • 9LOW RK, STOLLER ML. Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease[J]. J Urol, 1997,158(6):2062-2064. PMID: 9366312.
  • 10KAJANDER EO, CIFTCIOGLU N, AHO K, et al. Character isties of nanobacteria and their possible role in stone formation [J]. Urol Res,2003,31(2) 47-54. PMID.. 12669155.

二级参考文献34

  • 1Evan A P, Lingeman J E,Coe F L, Parks J H, Bledsoe S B, Shao Y,et al. Randall' s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle[J]. J Clin Invest,2003,111 : 607-616.
  • 2Coe F L, Evan A P, Worcester E. Kidney stone disease [J]. J Clin Invest, 2005,115 : 2598-2608.
  • 3Moe O W. Kidney stones: pathophysiology and medical management[J]. Lancet, 2006,367 : 333-344.
  • 4Matlaga B R,Coe F L,Evan A P,Lingeman J E. The role of Randall's plaques in the pathogenesis of calcium stones[J]. J Urol, 2007,177 : 31-38.
  • 5Matlaga B R,Williams J C Jr,Kim S C,Kuo R L,Evan A P, Bledsoe S B, et al. Endoscopic evidence of calculus attachment to Randall' s plaque[J]. J Urol, 2006,175 : 1720-1724.
  • 6Gambaro G, D' Angelo A, Fabris A, Tosetto E, Anglani F, Lupo A. Crystals, Randall' s plaques and renal stones: Do bone and atherosclerosis teach us something[J[. J Nephrol, 2004,17:774-777.
  • 7Stoller M L,Meng M V,Abrahams H M,Kane J P. The primary stone event: a new hypothesis involving a vascular etiology [J]. J Urol, 2004,171,1920-1924.
  • 8Fernandez-Conde M, Serrano S, Alcover J, Aaron J E. Bone metaplasia of urothelial mueosa:an unusual biological phenomenon causing kidney stones[J]. Bone, 1996,18:289-291.
  • 9Evan A P,Coe F L,Rittling S R,Bledsoe S B,Shao Y,Worcester E M,et al. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization [J]. Kidney Int,2005,68:145-154.
  • 10Peptan I A,Hong L,Evans C A. Multiple differentiation potentials of neonatal dura mater-derived cells [J]. Neurosurgery, 2007,60 : 346-352.

共引文献53

同被引文献46

  • 1陈志强,姚林方,叶章群.特发性草酸钙结石研究现状[J].临床泌尿外科杂志,2005,20(5):257-260. 被引量:38
  • 2安瑞华,冯陶,郭应禄,沈绍基.香豆素对实验性大鼠草酸钙结石形成的影响[J].中华泌尿外科杂志,1994,15(3):209-212. 被引量:35
  • 3AHMADI F, ETEMADI SM, LESSAN-PEZESHKI M, et al. Contribution of stone size to chronic kidney disease in kidney stone formers[J]. Int J Urol, 2015, 22(1):104-108.
  • 4GUL Z,MONGA M. Medical and dietary therapy for kidney stone prevention[J]. Korean J Urol, 2014, 55(12):775-779.
  • 5PATEL SR, NAKADA SY.The modern history and evolution of percutaneous nephrolithotomy[J]. J Endourol, 2015, 29(2): 153-157.
  • 6ZHAO Z, CUI Z, ZENG T,et al. Comparison of one-stage versus two-stages multiple -tracts mini-percutaneous nephrolithotomy for the reatment of staghorn stones: a matched cohorts analysis[J]. Urology, 2015, S0090-4295(15)00877-8.
  • 7HANDA RK, EVAN AP, WILLIS LR, et al. Renal functional effects of multiple-tract percutaneous access[J]. J Endourol, 2009, 23(12): 1951-1956.
  • 8DOMINGOS F, SERRA A.Metabolic syndrome: a multifaceted risk factor for kidney stones[J]. Scand J Urol, 2014, 48(5): 414-419.
  • 9KADLEC AO, GRECO K, FRIDIRICI ZC, et al. Metabolic syndrome and urinary stone composition: what factors matter most[J]? Urology, 2012, 80(4): 805-810.
  • 10KIREJCZYK JK, POROWSKI T, FILONOWICZ R, et al. An association between kidney stone composition and urinary metabolic disturbances in children[J]. J Pediatr Urol, 2014, 10(1):130-135.

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部